Sudo Biosciences
PrivateLast Round
Series B
Feb 13, 2024
Total Funding Raised
$214M
Momentum Score
25 /100
Company Overview
Sudo Biosciences is a biopharmaceutical company focused on developing innovative medicines that target the TYK2 pseudokinase domain to treat immune-mediated inflammatory conditions, including multiple sclerosis and neurodegenerative diseases, at a competitive cost.
Sector
Healthcare & Life Sciences
Verticals
Biotechnology, Drug Discovery, Clinical Trials, Precision Medicine
Business Model
B2B2C
Customer Profile
Revenue Share
AI Layer
Non-AI
Keywords
Historical Pricing
Historical view of private secondary pricing and transaction trends.
Sudo Biosciences Comps
Public and private peers based on sector, stage, and business model.
Sudo Biosciences Funding Rounds
Historical fundraising activity
| Round | Date | Amount Raised | Valuation | Investors | Sources |
|---|---|---|---|---|---|
| Series B | Feb 13, 2024 | ||||
| Series B | Jan 1, 2024 | ||||
| Series A | Sep 28, 2022 |
Sudo Biosciences Investors
Notable investors and investment history
| Investor | Rounds |
|---|---|
| TPG Life Sciences Innovations | Series B |
| Surveyor Capital | Series B |
| Enavate Sciences | Series B |
| Frazier Healthcare Partners | Series A |
| SV Health Investors | Series B |
| Northern Trust | Series B |
| Leaps by Bayer | Series B |
Market signals
Structured signals derived from secondary market and firmographic data.
- Dec 4, 2025
Paul S. Bavier appointed as Chief Legal Officer.
- Feb 13, 2024
$30M round completed.
Sudo Biosciences Filings
SEC and related filings with document metadata.
| Typed | Date | Amount Offered | Amount Sold | Filling | Pages | Download |
|---|---|---|---|---|---|---|
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Frequently Asked Questions
Common questions about Sudo Biosciences's valuation, stock price, and market status.
